Building Robust Clinical Supply Chains To Support Global Trials

Source: PCI Pharma Services

By Edward Groleau, PCI Pharma Services

Machine Converyor With Glass Vials GettyImages-498492002

Clinical trials are growing in complexity as sponsors aim to increase patient population diversity and reach patients around the world. Developing and maintaining a robust clinical supply chain is crucial to ensure investigational drugs are readily available at clinical sites when needed.

Understanding factors such as trial duration, patient recruitment rates, dosing schedules, and geographical distribution is a critical first step for accurately forecasting the demand for the investigational drug. Leveraging reliable suppliers for raw materials/APIs and packaging materials and working with global CDMOs with a local presence in your clinical trial territories can help to mitigate risk and build resilience in your supply chain. It is also crucial that both in-house operations and your global CDMO partners have the flexibility to quickly respond to unplanned events that will occur during the trial.

Ensuring investigational drugs reach patients at the right time and place is no simple feat. Review ten key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.

Subscribe to Clinical Supply Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Supply Leader